Progyny (PGNY) Cuts Guidance And Puts Its Valuation Back In Focus
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- PGNY Progyny
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Progyny belongs to, so it often moves with news about it.
- DVA DaVita
DaVita is a peer of Progyny in misc health and allied services; rivals often move on the same news.
- SHC Sotera Health
Sotera Health is a peer of Progyny in misc health and allied services; rivals often move on the same news.
- FMS Fresenius Medical Care AG
Fresenius Medical Care AG is a peer of Progyny in misc health and allied services; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| PGNY | -3.63% | -4.57% | base | +0.74% | -0.50% | +2.88% | +17.87% |
| XLV | -3.03% | -2.77% | base | -0.14% | -0.48% | +2.59% | +0.17% |
| DVA | -1.98% | -1.90% | base | -1.07% | -2.86% | +2.69% | +3.89% |
| SHC | +1.43% | +2.87% | base | -2.21% | -11.69% | -9.65% | -12.47% |
| FMS | +1.25% | +0.67% | base | +0.62% | -3.34% | +3.16% | +5.27% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Progyny (PGNY) Cuts Guidance And Puts Its Valuation Back In Focus Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| DVA | that day | -1.07% | final price |
| DVA | the next day | -2.86% | final price |
| DVA | two days later | +2.69% | final price |
| DVA | three days later | +3.89% | final price |
| DVA | three days earlier | -1.90% | final price |
| DVA | five days earlier | -1.98% | final price |
| FMS | that day | +0.62% | final price |
| FMS | the next day | -3.34% | final price |
| FMS | two days later | +3.16% | final price |
| FMS | three days later | +5.27% | final price |
| FMS | three days earlier | +0.67% | final price |
| FMS | five days earlier | +1.25% | final price |
| PGNY | that day | +0.74% | final price |
| PGNY | the next day | -0.50% | final price |
| PGNY | two days later | +2.88% | final price |
| PGNY | three days later | +17.87% | final price |
| PGNY | three days earlier | -4.57% | final price |
| PGNY | five days earlier | -3.63% | final price |
| SHC | that day | -2.21% | final price |
| SHC | the next day | -11.69% | final price |
| SHC | two days later | -9.65% | final price |
| SHC | three days later | -12.47% | final price |
| SHC | three days earlier | +2.87% | final price |
| SHC | five days earlier | +1.43% | final price |
| XLV | that day | -0.14% | final price |
| XLV | the next day | -0.48% | final price |
| XLV | two days later | +2.59% | final price |
| XLV | three days later | +0.17% | final price |
| XLV | three days earlier | -2.77% | final price |
| XLV | five days earlier | -3.03% | final price |
This story
12 out of 100
“Progyny (PGNY) Cuts Guidance And Puts Its Valuation Back In Focus” scores 12 out of 100. The score uses 1 sources.